Building India's Precision Medicine Ecosystem, From Sequencing to Local Manufacturing

Precision medicine is redefining healthcare by enabling faster, more accurate and personalised treatment strategies. Harkaran Dhingra, CEO, DSS Takara Bio India, shares with Pharma Industrial India, insights on India’s precision medicine landscape, the expanding use of Next Generation Sequencing (NGS), gene editing, RNA therapeutics, single-cell technologies, local manufacturing under the ‘Make in India’ initiative, and the collaborations accelerating research and clinical innovation.